285. ファンコニ貧血 Fanconi anemia Clinical trials / Disease details

臨床試験数 : 59 / 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04483544 (ClinicalTrials.gov)	August 10, 2020	20/7/2020	Pembrolizumab and Olaparib in Cervical Cancer Patients	Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally ...	Cervical Cancer;Cervical Carcinoma	Drug: pembrolizumab;Drug: olaparib	Baptist Health South Florida	Florida Department of Health;Merck Sharp & Dohme Corp.	Recruiting	18 Years	N/A	Female	48	Phase 2	United States
2	NCT04042831 (ClinicalTrials.gov)	June 9, 2020	29/7/2019	Olaparibin Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Muta ...	A Phase II Study of Olaparibin Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair ...	BRCA2 Gene Mutation;BRIP1 Gene Mutation;CHEK2 Gene Mutation;EMSY Gene Mutation;Fanconi Anemia Comple ...	Drug: Olaparib	Academic and Community Cancer Research United	National Cancer Institute (NCI)	Recruiting	18 Years	N/A	All	36	Phase 2	United States

First Previous1Next Last